176 related articles for article (PubMed ID: 34262915)
1. The Scientific and Clinical Case for Reviewing Diagnostic Radiopharmaceutical Extravasation Long-Standing Assumptions.
Osborne D; Lattanze R; Knowland J; Bryant TE; Barvi I; Fu Y; Kiser JW
Front Med (Lausanne); 2021; 8():684157. PubMed ID: 34262915
[No Abstract] [Full Text] [Related]
2. Patient-specific Extravasation Dosimetry Using Uptake Probe Measurements.
Osborne D; Kiser JW; Knowland J; Townsend D; Fisher DR
Health Phys; 2021 Mar; 120(3):339-343. PubMed ID: 33443961
[TBL] [Abstract][Full Text] [Related]
3. Dose Estimation for Extravasation of 177Lu, 99mTc, and 18F.
Tsorxe IY; Hayes RB
Health Phys; 2023 Mar; 124(3):217-220. PubMed ID: 36719937
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. Practical Tools for Patient-specific Characterization and Dosimetry of Radiopharmaceutical Extravasation.
Wilson S; Osborne D; Long M; Knowland J; Fisher DR
Health Phys; 2022 Nov; 123(5):343-347. PubMed ID: 35838538
[TBL] [Abstract][Full Text] [Related]
7. Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review.
van der Pol J; Vöö S; Bucerius J; Mottaghy FM
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1234-1243. PubMed ID: 28303300
[TBL] [Abstract][Full Text] [Related]
8. Safety injections of nuclear medicine radiotracers: towards a new modality for a real-time detection of extravasation events and
Iori M; Grassi E; Piergallini L; Meglioli G; Botti A; Sceni G; Cucurachi N; Verzellesi L; Finocchiaro D; Versari A; Fraboni B; Fioroni F
EJNMMI Phys; 2023 May; 10(1):31. PubMed ID: 37221434
[TBL] [Abstract][Full Text] [Related]
9. Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing
Parihar AS; Schmidt LR; Crandall J; Dehdashti F; Wahl RL
J Nucl Med; 2023 Mar; 64(3):485-490. PubMed ID: 36265907
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody extravasations: Two case reports and literature review.
Rodríguez-Alarcón A; Conde-Estévez D
J Oncol Pharm Pract; 2021 Apr; 27(3):761-763. PubMed ID: 32799778
[TBL] [Abstract][Full Text] [Related]
11. Tissue dose estimation after extravasation of
Tylski P; Pina-Jomir G; Bournaud-Salinas C; Jalade P
EJNMMI Phys; 2021 Mar; 8(1):33. PubMed ID: 33788043
[TBL] [Abstract][Full Text] [Related]
12. Radiation Safety and Accidental Radiation Exposures in Nuclear Medicine.
Marengo M; Martin CJ; Rubow S; Sera T; Amador Z; Torres L
Semin Nucl Med; 2022 Mar; 52(2):94-113. PubMed ID: 34916044
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Topical Sensor for the Assessment of Injection Quality for 18F-FDG, 68Ga-PSMA and 68Ga-DOTATATE Positron Emission Tomography.
Sanchez S; Currie GM
J Med Imaging Radiat Sci; 2020 Jun; 51(2):247-255. PubMed ID: 32089515
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceutical Extravasation: Pragmatic Radiation Protection.
Fisher DR; Liverett M
Health Phys; 2022 Apr; 122(4):537-539. PubMed ID: 35085120
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
17. MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature.
Bolch WE; Eckerman KF; Sgouros G; Thomas SR
J Nucl Med; 2009 Mar; 50(3):477-84. PubMed ID: 19258258
[TBL] [Abstract][Full Text] [Related]
18. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
19. Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer.
Beauregard JM
Cancer Imaging; 2022 Dec; 22(1):67. PubMed ID: 36494731
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric consequences of radiopharmaceutical infiltrations.
Castronovo FP; McKusick KA; Strauss HW
Invest Radiol; 1994 Jan; 29(1):59-64. PubMed ID: 8144339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
